No title
Lipid nanoparticles (LNPs) are vesicular structures composed of phospholipids commonly used in vaccine formulations due to their ability to protect and encapsulate mRNA for efficient delivery to target cells. This delivery system was pivotal for the rapid development of COVID-19 mRNA vaccines. Efficient mRNA delivery depends on the particle size and stability of LNPs, making these key parameters t
